SCHWARZ PHARMA secures future neurology projects
Advertisement
SCHWARZ PHARMA and the Neurozentrum of the Universitätsklinikum Freiburg have agreed on a cooperation in the field of neuro-degenerative diseases. A whole substance class targeting this therapeutic area is to be jointly tested and further developed. UF09200 is the lead compound among these molecules.
SCHWARZ PHARMA acquires the worldwide rights to all substances originating from this cooperation that prove effective in the treatment of neuro-degenerative diseases. The project is at the early pre-clinical stage.
"This cooperation adds further attractive potential to our development pipeline. With Professor Feuerstein from the Neurologischen Univer-sitätsklinik, we have gained an excellent partner with a high international reputation in the field of neuropharmacology." said Dr. Dr. Lars Ekman, Executive Board member of SCHWARZ PHARMA AG and responsible for Research and Development. "Our aim is to continue expanding our CNS pipeline. For this reason, we are constantly exam-ining promising opportunities. We are confident that further innovative projects will follow this year."
Most read news

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Great Lakes and Teijin Chemicals intend to combine their global brominated carbonate oligomer activities

SAMPLES | Laboratory information management systems | qualitype
Europe at the cutting edge of nanotechnology development
High-resolution measurement of photocurrents

Joining metals without welding - Prototype for new connection technology
Great Lakes Chemical Eliminates Price Protection For Flame Retardants And Brominated Performance Products

Cooperation with Namibia underway - Natural resources as a basis for new materials
Expanded compounding activities: Polymer Group aims for the 200,000 tonnes mark - Based on its record of continuous growth, the Polymer Group s aiming for an overall compounding volume of 200,000 MT/a for the first time ever in 2009
Asset swap between Wintershall and Statoil completed - Oil and gas production in Norway rises from around 3,000 barrels to almost 40,000 barrels of oil equivalent (boe) per day
